Research and Progress
Texas Tribune: The Rio Grande Valley is at the epicenter of an Alzheimer’s spike among Latinos and is now the focus of new research efforts
February 4, 2023
Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, speaks to the spike of Alzheimer’s disease in South Texas and how in partnership with the University of Texas Rio Grande Valley, the institute is looking at why there are so many cases in South […]
Alzheimer’s disease clinical trial seeks 21 area volunteers
January 30, 2023
Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The study, called SToMP-AD (Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease), seeks 21 San […]
UT Health San Antonio specialists to discuss latest treatments of movement disorders
January 26, 2023
Deep brain stimulation, continuous levodopa infusion among topics Four fellowship-trained movement disorders neurologists from UT Health San Antonio will give talks Friday (Jan. 27) at the Parkinson’s Foundation Tri-State Symposium. These physicians will discuss the newest developments in research and clinical trials of Parkinson’s disease and other disorders. The symposium, free and open to the […]
A new era in Alzheimer’s treatment: FDA approval on lecanemab
January 11, 2023
Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]
Texas Public Radio: Clinical trial for first Alzheimer’s drug with effect on cognitive decline looks for South Texas recruits
December 9, 2022
Arash Salardini, MD, neurologist at the Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed for this story on Texas Public Radio (KSTX) on a clinical trial in South Texas for a drug to treat cognitive decline. The clinical trial, AHEAD 3-45, is to assess whether IV infusions of the antibody (lecanemab) can delay cognitive […]
Can Alzheimer’s disease be delayed or stopped before the symptoms begin? A new clinical trial strives to find answers.
December 1, 2022
The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. Lecanemab has aroused some excitement recently and has been covered extensively by the media. A separate Phase III clinical trial, published Nov. 29 in The New England […]
KatieCouric.com: How to Spot the Warning Signs of Brain Trauma — And Prevent the Injuries That Lead to It
November 28, 2022
Did you know you can have chronic traumatic encephalopathy (CTE) from head trauma even if you are not an athlete or have served in the military? Chronic traumatic encephalopathy (CTE) is caused by repeated traumatic brain injuries. Most people are unaware they had brain trauma and ignore symptoms of CTE unless they are in […]
Dozens more genes linked with stroke; potential drug targets identified
September 28, 2022
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are part of an international team that discovered 61 additional genetic loci associated with stroke and six genes that are potential targets for drug therapy to prevent or treat stroke. The findings, published today (Sept. 28) in Nature, are […]
Alzheimer’s Weekly: Success in Delaying Dementia
August 15, 2022
Sudha Seshadri, MD, professor of neurology and founding director of the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Health San Antonio, discusses her latest research surrounding the trend of people developing dementia later in life and the relation to strokes. To read the article, visit AlzheimersWeekly.com.
Scientists hope to create a health ‘scorecard’ for dementia risk
July 5, 2022
UT Health San Antonio is site for a new major study of diverse communities is looking at how brain changes and genetics contribute to dementia and Alzheimer’s. UT Health San Antonio is a clinical research site for a new study, Diverse Vascular Contributions to Cognitive Impairment and Dementia, or Diverse VCID. by UC […]